• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland
Conclusions In this large prospective ACS cohort, patients treated with prasugrel according to current guidelines (ie, in patients without cerebrovascular disease, old age or underweight) had a similar safety profile compared with patients treated with clopidogrel. Clinical trial registration number SPUM-ACS: NCT01000701; COMFORTABLE AMI: NCT00962416.
Source: Heart - May 12, 2015 Category: Cardiology Authors: Klingenberg, R., Heg, D., Raber, L., Carballo, D., Nanchen, D., Gencer, B., Auer, R., Jaguszewski, M., Stahli, B. E., Jakob, P., Templin, C., Stefanini, G. G., Meier, B., Vogt, P., Roffi, M., Maier, W., Landmesser, U., Rodondi, N., Mach, F., Windecker, S. Tags: Drugs: cardiovascular system, Acute coronary syndromes, Epidemiology Coronary artery disease Source Type: research